Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Effect of acetazolamide on visuomotor performance at high altitude in healthy people 40 years of age or older—RCT

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Ceruti, Samuele; Ceruti, S ( Samuele )
    • بيانات النشر:
      Public Library of Science (PLoS)
    • الموضوع:
      2023
    • Collection:
      University of Zurich (UZH): ZORA (Zurich Open Repository and Archive
    • نبذة مختصرة :
      Objective: Altitude travel is increasingly popular also for middle-aged and older tourists and professionals. Due to the sensitivity of the central nervous system to hypoxia, altitude exposure may impair visuomotor performance although this has not been extensively studied. Therefore, we investigated whether a sojourn at moderately high altitude is associated with visuomotor performance impairments in healthy adults, 40y of age or older, and whether this adverse altitude-effect can be prevented by acetazolamide, a drug used to prevent acute mountain sickness. Methods: In this randomized placebo-controlled parallel-design trial, 59 healthy lowlanders, aged 40-75y, were assigned to acetazolamide (375 mg/day, n = 34) or placebo (n = 25), administered one day before ascent and while staying at high altitude (3100m). Visuomotor performance was assessed at 760m and 3100m after arrival and in the next morning (post-sleep) by a computer-assisted test (Motor-Task-Manager). It quantified deviation of a participant-controlled cursor affected by rotation during target tracking. Primary outcome was the directional error during post-sleep recall of adaptation to rotation estimated by multilevel linear regression modeling. Additionally, adaptation, immediate recall, and correct test execution were evaluated. Results: Compared to 760m, assessments at 3100m with placebo revealed a mean (95%CI) increase in directional error during adaptation and immediate recall by 1.9° (0.2 to 3.5, p = 0.024) and 1.1° (0.4 to 1.8, p = 0.002), respectively. Post-sleep recall remained unchanged (p = NS), however post-sleep correct test execution was 14% less likely (9 to 19, p<0.001). Acetazolamide improved directional error during post-sleep recall by 5.6° (2.6 to 8.6, p<0.001) and post-sleep probability of correct test execution by 36% (30 to 42, p<0.001) compared to placebo. Conclusion: In healthy individuals, 40y of age or older, altitude exposure impaired adaptation to and immediate recall and correct execution of a visuomotor task. ...
    • File Description:
      application/pdf
    • ISSN:
      1932-6203
    • Relation:
      https://www.zora.uzh.ch/id/eprint/240060/1/ZORA_journal_pone_0280585.pdf; info:pmid/36662903; urn:issn:1932-6203
    • الرقم المعرف:
      10.5167/uzh-240060
    • الرقم المعرف:
      10.1371/journal.pone.0280585
    • Rights:
      info:eu-repo/semantics/openAccess ; Creative Commons: Attribution 4.0 International (CC BY 4.0) ; http://creativecommons.org/licenses/by/4.0/
    • الرقم المعرف:
      edsbas.DF97C7FC